Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors

Transcriptional silencing of HIV generates a reservoir of latently infected cells, but the mechanisms that lead to this outcome are not well understood. We characterized a primary cell model of HIV latency, and observed that latency is a stable, heritable viral state that is rapidly reestablished after stimulation. Using Assay of Transposon-Accessible Chromatin sequencing (ATACseq) we found that latently infected cells exhibit reduced proviral accessibility, elevated activity of Forkead and Kruppel-like factor transcription factors (TFs), and reduced activity of AP-1, RUNX and GATA TFs. Latency reversing agents caused distinct patterns of chromatin reopening across the provirus. Furthermore, depletion of a chromatin domain insulator, CTCF inhibited HIV latency, identifying this factor as playing a key role in the initiation or enforcement of latency. These data indicate that HIV latency develops preferentially in cells with a distinct pattern of TF activity that promotes a closed proviral structure and inhibits viral gene expression.

[1]  Guillaume J. Filion,et al.  The chromatin landscape at the HIV-1 provirus integration site determines viral expression , 2020, Nucleic acids research.

[2]  E. Verdin,et al.  FOXO1 promotes HIV Latency by suppressing ER stress in T cells , 2020, Nature Microbiology.

[3]  G. Vahedi,et al.  Joint profiling of chromatin accessibility and CAR-T integration site analysis at population and single-cell levels , 2020, Proceedings of the National Academy of Sciences.

[4]  B. Liao,et al.  Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo , 2020, Nature.

[5]  Li-Hsin Chang,et al.  TADs and their borders: free movement or building a wall? , 2019, Journal of molecular biology.

[6]  D. Reinberg,et al.  RNA Interactions Are Essential for CTCF-Mediated Genome Organization. , 2019, Molecular cell.

[7]  R. Tjian,et al.  Distinct Classes of Chromatin Loops Revealed by Deletion of an RNA-Binding Region in CTCF. , 2019, Molecular cell.

[8]  R. Cheynier,et al.  FOXO1 transcription factor plays a key role in T cell—HIV-1 interaction , 2019, PLoS pathogens.

[9]  F. Margottin-Goguet,et al.  HUSH, a Link Between Intrinsic Immunity and HIV Latency , 2019, Front. Microbiol..

[10]  Andrea J. Kriz,et al.  Exploration of CTCF post-translation modifications uncovers Serine-224 phosphorylation by PLK1 at pericentric regions during the G2/M transition , 2019, eLife.

[11]  S. Rutz,et al.  Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells , 2018, Current protocols in immunology.

[12]  Guillaume J. Filion,et al.  Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 , 2018, bioRxiv.

[13]  B. Haynes,et al.  Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency. , 2018, Cell reports.

[14]  Akiko Seki,et al.  Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells , 2018, The Journal of experimental medicine.

[15]  D. Bloom,et al.  Depletion of the Insulator Protein CTCF Results in Herpes Simplex Virus 1 Reactivation In Vivo , 2018, Journal of Virology.

[16]  J. Schiffer,et al.  A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation , 2018, bioRxiv.

[17]  W. Greene,et al.  Chromatin Functional States Correlate with HIV Latency Reversal in Infected Primary CD4+ T cells , 2018, bioRxiv.

[18]  J. Mellors,et al.  Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART , 2017, Proceedings of the National Academy of Sciences.

[19]  Geet Duggal,et al.  Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.

[20]  C. Tiemessen,et al.  Mechanisms of HIV persistence in HIV reservoirs , 2017, Reviews in medical virology.

[21]  K. Willard-Gallo,et al.  FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders , 2017, European journal of immunology.

[22]  K. Yoshimura.  Current status of HIV/AIDS in the ART era. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[23]  I. Mills,et al.  CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions , 2016, Nucleic acids research.

[24]  B. Walker,et al.  Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. , 2016, Cell host & microbe.

[25]  Andrew J. Grimm,et al.  Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission , 2016, PLoS pathogens.

[26]  M. Lichterfeld,et al.  Diversity of HIV-1 reservoirs in CD4+ T-cell subpopulations , 2016, Current opinion in HIV and AIDS.

[27]  Rodolfo Ghirlando,et al.  CTCF: making the right connections , 2016, Genes & development.

[28]  Valentina Boeva,et al.  Analysis of Genomic Sequence Motifs for Deciphering Transcription Factor Binding and Transcriptional Regulation in Eukaryotic Cells , 2016, Front. Genet..

[29]  S. Valente,et al.  Didehydro-Cortistatin A: a new player in HIV-therapy? , 2016, Expert review of anti-infective therapy.

[30]  Aaron T. L. Lun,et al.  csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows , 2015, Nucleic acids research.

[31]  Daniel S. Day,et al.  Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.

[32]  Nancie M Archin,et al.  Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. , 2015, The Journal of infectious diseases.

[33]  Alexander Dobin,et al.  Mapping RNA‐seq Reads with STAR , 2015, Current protocols in bioinformatics.

[34]  G. Pantaleo,et al.  The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo , 2015, PLoS pathogens.

[35]  Anthony D. Kelleher,et al.  HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission , 2015, PLoS pathogens.

[36]  Howard Y. Chang,et al.  Single-cell chromatin accessibility reveals principles of regulatory variation , 2015, Nature.

[37]  D. Margolis,et al.  H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells , 2015, Journal of Virology.

[38]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[39]  Igor M. Rouzine,et al.  A Hardwired HIV Latency Program , 2015, Cell.

[40]  Howard Y. Chang,et al.  ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.

[41]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[42]  D. Margolis,et al.  Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4+ T Cells , 2014, Journal of Virology.

[43]  Amy S. Espeseth,et al.  Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection , 2014, PloS one.

[44]  S. Hughes,et al.  Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2014, Science.

[45]  M. Lederman,et al.  HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality , 2014, PLoS pathogens.

[46]  D. Margolis.  How Might We Cure HIV? , 2014, Current Infectious Disease Reports.

[47]  R. Siliciano,et al.  Unique characteristics of histone deacetylase inhibitors in reactivation of latent HIV-1 in Bcl-2-transduced primary resting CD4+ T cells. , 2014, The Journal of antimicrobial chemotherapy.

[48]  I. Sadowski,et al.  Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB , 2014, Retrovirology.

[49]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[50]  Wouter de Laat,et al.  CTCF: the protein, the binding partners, the binding sites and their chromatin loops , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[51]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[52]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[53]  M. Lederman,et al.  Residual immune dysregulation syndrome in treated HIV infection. , 2013, Advances in immunology.

[54]  B. Berkhout,et al.  An AP-1 Binding Site in the Enhancer/Core Element of the HIV-1 Promoter Controls the Ability of HIV-1 To Establish Latent Infection , 2012, Journal of Virology.

[55]  Matthew T. Maurano,et al.  Widespread plasticity in CTCF occupancy linked to DNA methylation , 2012, Genome research.

[56]  J. Eron,et al.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy , 2012, Nature.

[57]  Davis J. McCarthy,et al.  Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.

[58]  T. Mahmoudi,et al.  Repressive LTR Nucleosome Positioning by the BAF Complex Is Required for HIV Latency , 2011, PLoS biology.

[59]  M. Lederman,et al.  Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. , 2011, The Journal of infectious diseases.

[60]  Jonathan Karn,et al.  T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. , 2011, Journal of molecular biology.

[61]  J. Karn,et al.  Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2 , 2011, Journal of Virology.

[62]  S. Lewin,et al.  Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection. , 2011, Biomarkers in medicine.

[63]  R. Siliciano,et al.  HIV latency. , 2011, Cold Spring Harbor perspectives in medicine.

[64]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[65]  J. Karn,et al.  Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction , 2010, Journal of Virology.

[66]  Hao Zhang,et al.  Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. , 2009, The Journal of clinical investigation.

[67]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[68]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[69]  Robert Gentleman,et al.  rtracklayer: an R package for interfacing with genome browsers , 2009, Bioinform..

[70]  J. Karn,et al.  Epigenetic Silencing of Human Immunodeficiency Virus (HIV) Transcription by Formation of Restrictive Chromatin Structures at the Viral Long Terminal Repeat Drives the Progressive Entry of HIV into Latency , 2008, Journal of Virology.

[71]  P. Lieberman,et al.  Regulation of Epstein-Barr Virus Latency Type by the Chromatin Boundary Factor CTCF , 2006, Journal of Virology.

[72]  Jared E. Toettcher,et al.  Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity , 2005, Cell.

[73]  R. Siliciano,et al.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.

[74]  D. Margolis,et al.  The regulation of HIV-1 gene expression: the emerging role of chromatin. , 2002, DNA and cell biology.

[75]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[76]  D. Gabuzda,et al.  ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-κB* , 1999, The Journal of Biological Chemistry.

[77]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[78]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[79]  M. Kagnoff,et al.  Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. , 1996, AIDS (London).

[80]  J. D. Engel,et al.  Human T cell transcription factor GATA-3 stimulates HIV-1 expression. , 1993, Nucleic acids research.

[81]  G. Nabel,et al.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells , 1987, Nature.